TRIESENCE
NDC 82667-800, triamcinolone acetonide, injection, suspension, from Harrow Eye, LLC.
- Product NDC
- 82667-800
- Status
- Listed
- Labeler
- Harrow Eye, LLC
- Dosage form
- INJECTION, SUSPENSION
- Route
- OPHTHALMIC
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022048
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82667-800 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRIAMCINOLONE ACETONIDE40 mg/mL
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82667-800-01 | 82667080001 | 1 BLISTER PACK in 1 CARTON (82667-800-01) / 1 VIAL, GLASS in 1 BLISTER PACK / 1 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/2267978c-72ad-9229-e063-6394a90a09d0Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=82667-800
Use it
Look up 82667-800 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82667-800 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82667-800. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.